Dr Kip Dudgeon

Scientific Advisor

Prior to joining Magellan, Kip was Manager of Commercial Operations and Corporate Development at the newly established Kinghorn Centre for Clinical Genomics, a division of Sydney’s Garvan Institute of Medical Research. There, he helped establish one of the world’s first clinical genomics companies, GenomeOne.

Previously, he was Business Development Manager at the Garvan, helping the Institute’s researchers commercialise their discoveries through partnership with biopharmaceutical companies and venture capital investors. He has extensive therapeutic drug development experience, working at several early-stage biotechnology companies including G2 Therapies and 3M Health.

Kip has a first class honours degree in science from UNSW Australia, and conducted his PhD in Medicine at the Garvan Institute of Medical Research. His research has generated over a dozen peer-reviewed articles and several worldwide patents that led to the formation of start-up biotechnology company, Solvanix Pty Ltd, in 2015.